In a recent Reuters article, GSK signs deal with sport's World Anti-Doping Agency, Kate Kelland highlights the agreement between WADA and GlaxoSmithKline that allows GSK to “supply WADA with confidential information about medicines in early stage development that may be abused by athletes once licensed…”
What this does is allow WADA to develop testing methods early in the process, thus, giving them an advantage over the users. An advantage that athletes using illegal performing-enhancing drugs had before by being ahead of the testing curve through their use of undetectable substances.
It sure is nice to see a major drug manufacturer take initiative to make a difference in the war on illegal performance-enhancement. If WADA can secure more of these types of agreements, continue their efforts to test athletes earlier in the process, and find better and more sophisticated testing methods, things may actually start to change.
Score “1” for the good guys here!!!